-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster II

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Marco Ruella, MD1, David M. Barrett, MD, PhD2*, Saad S Kenderian, MD1,3, Olga Shestova, PhD1*, Ted J. Hofmann, PhD2*, John Scholler4*, Simon F. Lacey, PhD, BSc1*, J. Joseph Melenhorst, PhD1, Farzana Nazimuddin5*, Jessica Perazzelli, PhD2*, David A Christian, PhD6*, Christopher A Hunter, PhD6*, David L Porter, MD7, Carl H. June, MD1, Stephan A. Grupp, MD, PhD2 and Saar I Gill, MBBS, PhD1

1Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
2Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
3Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN
4Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
5Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
6Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA
7Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Elad Jacoby, MD, Sang Minh Nguyen, BS*, Kathryn M Welp*, Haiying Qin, MS*, Yinmeng Yang, BS*, Christopher Daniel Chien, PhD, John Shern, M.D.* and Terry J. Fry, M.D.

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

EunJi Gang, MD PhD1*, Yao-Te Hsieh, PhD2*, Hye Na Kim1*, Yann Duchartre, PhD3*, Shishido Stephanie, PhD3*, Markus Muschen, MD4, Elizabeth Wayner, PhD3*, Nora Heisterkamp, PhD5*, Halvard Bonig, MD, MA6 and Yong-Mi Kim, MD PhD MPH5

1Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles
2Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA
3Children's Hospital Los Angeles, University of Southern California, Los Angeles
4Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA
5Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA
6German Red Cross Blood Centre and Institute for Transfusion Medicine and Immunohematology, Johann-Wolfgang-Goethe University, Hematopoietic Cell Research Group, Frankfurt, Germany

EunJi Gang, MD PhD1*, Hye Na Kim1*, Yann Duchartre, PhD1*, Stephanie Nicole Shishido, PhD2*, Sajad Khazal, MD2*, Etai Adam, MD3*, Nour Abdel-Azim1*, Chintan Parekh, MBBS1*, Hisham Abdel-Azim, MD2, Deepa Bhojwani, MD1*, Nora Heisterkamp, PhD2*, Alan S. Wayne, MD2 and Yong-Mi Kim, MD PhD MPH2

1Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles
2Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA
3Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles

Aaron Chang1*, Tao Dao, PhD1*, Andrew Scott1*, Leonid Dubrovsky, MD1*, Cheng Liu, PhD2* and David A. Scheinberg, MD, PhD1

1Molecular Pharmacology and Chemistry Program, Sloan Kettering Institute, New York, NY
2Eureka Therapeutics, Emeryville, CA

Tara Bree Gavcovich, BS1,2, Kirsti Lorraine Walker, BS, MS1, Myriam N. Bouchlaka, BS, PhD3 and Christian M Capitini, MD4*

1Department of Pediatric and Carbone Cancer Center, UW Madison, Madison, WI
2School of Medicine and Health Sciences, George Washington University, Washington, DC
3Department of Pediatrics and Carbone Cancer Center, University of Madison, Wisconsin, Madison, WI
4Department of Pediatric and Carbone Cancer Center, University of Wisconsin, Madison, WI

Ce Shi, PhD1,2*, Lina Han, PhD1*, Qi Zhang3*, Kathryn G. Roberts4, Eugene Park5*, Yoko Tabe, MD, PhD6, Rodrigo Omar Jacamo, PhD3*, Hong Mu, MD, PhD7*, Shuo-Chieh Wu8*, Jin Zhou9*, Helen Ma1*, Zhihong Zeng, MD10, Nitin Jain, MD1, Elias J Jabbour, MD1, Markus Muschen, MD PhD11, Sarah K Tasian, MD12, Charles G. Mullighan, MBBS, MSc, MD13, David M. Weinstock14, David Fruman, PhD15* and Marina Konopleva, MD, PhD10

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, First Affiliated Hospital, Harbin Medical University, Harbin, China
3Section of Molecular Hematology & Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Pathology, St. Jude Children's Research Hospital, Memphis, TN
5Department of Haematology, University of Cambridge, Cambridge, United Kingdom
6Juntendo University School of Medicine, Toyko, Japan
7Section of Molecular Hematology and Therapy, Leukemia Department, UT MD Anderson Cancer Center, Houston, TX
8Dana-Farber Cancer Institute, Boston, MD
9Department of Medicine, Hematology, The First Hospital Affiliated Harbin Medical University, Harbin, China
10Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
11Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA
12Pediatric Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA
13Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
14Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
15University of California, Irvine, Irvine, CA

Yogin B Patel, PharmD1*, Hagop M. Kantarjian, MD2, Deborah Thomas, MD2, Susan O'Brien, MD3, Farhad Ravandi, MD2, Guillermo Garcia-Manero, MD4, Jorge E. Cortes2, Marina Konopleva, MD, PhD2, Nitin Jain, MD2, Rebecca Garris2*, Jane Autry, RN5* and Elias Jabbour2

1Division of Pharmacy and Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3University of California - Irvine, Orange, CA
4Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Houston, TX
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

Paraskevi Diamanti, BSc, PhD1*, William J Barendt, BSc2*, Benjamin C Ede, BSc2*, Charlotte V. Cox, BSc3* and Allison Blair, PhD, BSc2,3

1NHS Blood and Transplant, Bristol Institute for Transfusion Sciences, Bristol, England
2School of Cellular & Molecular Medicine, University of Bristol, Bristol, United Kingdom
3Bristol Institute for Transfusion Sciences, NHS Blood & Transplant, Bristol, United Kingdom

Viktoras Frismantas, MSc1*, Maria Pamela Dobay, PhD2*, Anna Rinaldi, PhD1*, Kunz Joachim, MD3*, Blerim Marovca4*, Peter Horvath, PhD5*, Mauro Delorenzi, PhD2*, Gunnar Cario, MD6*, Martin Schrappe, MD7, Martin Stanulla, MD8*, Andreas E. Kulozik, MD, PhD9, Martina U. Muckenthaler, PhD10, Arend Stackelberg, MD11*, Cornelia Eckert11*, Thomas Radimerski, PhD12*, Beat Bornhauser, PhD13* and Jean-Pierre Bourquin, MD, PhD4

1Department of Oncology, University Children’s Hospital, Zurich, Switzerland
2Swiss Institute of Bioinformatics, Lausanne, Switzerland
3Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Angelika Lautenschläger Children's Hospital, Heidelberg, Germany
4Department of Oncology, University Children’s Hospital Zurich, Zurich, Switzerland
5Synthetic and Systems Biology Unit, University of Szeged, Szeged, Hungary
6Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany
7Dept. of Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
8Department of Paediatric Haematology and Oncology, Hannover Medical School, Hannover, Germany
9Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany
10Department of Pediatric Oncology, Hematology, Immunology and Pulmunology, University of Heidelberg, Heidelberg, Germany
11Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin, Berlin, Germany
12Disease Area Oncology, Novartis Institute for Biomedical Research, Basel, Switzerland
13Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland

Kevin J. Curran, MD1,2, Isabelle Riviere, PhD2,3, Lewis B. Silverman, MD4,5, Rachel Kobos, MD1*, Neerav Shukla, MD1*, Peter G Steinherz, MD1, Farid Boulad, MD1,2, Susan Prockop, MD1, Andromachi Scaradavou, MD1, Steven P. Margossian, MD, PhD5,6, Xiuyan Wang, PhD2*, Yongzeng Wang, PhD2*, Victoria Szenes, NP1*, Colleen H Dansereau, MSN, RN5*, Brenda MacKinnon, RN5*, Craig S. Sauter, MD7, Jae H. Park, MD8, Nancy A. Kernan, MD1,2, Richard J O'Reilly, MD1,2*, Michel Sadelain, MD, PhD2,3 and Renier J. Brentjens, MD, PhD2,8

1Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
2Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA
5Division of Pediatric Hematology, Boston Children's Hospital, Boston, MA
6Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
7Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
8Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

Angela Maria Savino1*, Jolanda Sarno1*, Luca Trentin2*, Margherita Vieri1*, Grazia Fazio, PhD1*, Michela Bardini1*, Cristina Bugarin3*, Gianluca Fossati4*, Kara L. Davis, DO5, Giuseppe Gaipa, PhD3, Lueder Hinrich Meyer, MD6*, Garry P. Nolan, Prof, PhD7*, Andrea Biondi, Prof, MD8, Geertruy Te Kronnie, PhD9*, Chiara Palmi, PhD3* and Giovanni Cazzaniga1

1Centro Ricerca Tettamanti, Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
22. Department of Women’s and Children’s Health, University of Padova, Padova, Italy
3Department of Pediatrics, Tettamanti Research Center, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
43. Preclinical R&D Department, Italfarmaco S.p.A., Cinisello Balsamo, Milano, Italy
5Pediatrics, Stanford University, Palo Alto, CA
6Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
7Department of Microbiology and Immunology, Baxter Laboratory for Stem Cell Biology, Stanford University School of Medicine, Palo Alto, CA
8Centro Ricerca Tettamanti, Clinica Pediatrica, Università Milano Bicocca, Osp. San Gerardo/Fondazione MBBM, Monza (MB), Italy
9Department of Women’s and Children’s Health, University of Padova, Padova, Italy

*signifies non-member of ASH